arrow
R

Rikke Andersen

University of Copenhagen
H指数:28
被引数:3,370

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: a nationwide cohort study of 2,127 patients with melanoma, RCC, and NSCLC

对PD-1/PD-L1阻断治疗的应答者中进展风险主要由应答深度分层:一项涉及2,127例黑素瘤、肾细胞癌和非小细胞肺癌患者的大型队列研究

2026-06-050
OAAI
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma

新抗原反应性CD8 T细胞影响黑色素瘤肿瘤浸润淋巴细胞过继细胞治疗的临床结果

2022-01-1873
OAAI
Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations

来自透明细胞肾细胞癌患者的肿瘤浸润性T细胞识别源自点突变和移码突变的新表位

2020-03-1235
OAAI
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling
2017-08-3139
OAAI